Jon Kessler - HealthEquity CEO and President and Director
| HQY Stock | USD 102.47 1.10 1.06% |
CEO
Mr. Jon Kessler is a President, Chief Executive Officer, Director of the Company. Mr. Kessler has served as our President and Chief Executive Officer since February 2014 and as a director since March 2009. From March 2009 through January 2014, he served as our Executive Chairman. Prior to joining HealthEquity, Mr. Kessler founded WageWorks, Inc., a provider of taxadvantaged programs for consumercentric health, commuter and other employee spending account benefits, serving as Chief Executive Officer of that company from 2000 to 2004, Executive Chairman in 2005, and Chief Executive Officer from 2006 to 2007. Prior to founding WageWorks, Inc., Mr. Kessler was a benefits taxation specialist at Arthur Andersen, LLP and, prior to that, he was a senior economist in Washington, D.C., specializing in employee benefits and environmental taxation during the Clinton and Bush administrations. Mr. Kessler also currently serves as a trustee of the Employee Benefits Research Institute and a director of the International Baccalaureate Organization, both nonprofit organizations since 2014.
| Age | 56 |
| Tenure | 10 years |
| Address | 15 West Scenic Pointe Drive, Draper, UT, United States, 84020 |
| Phone | 801 727 1000 |
| Web | https://www.healthequity.com |
Latest Insider Transactions
Kessler holds a B.A. from George Washington University in International Affairs and an M.P.P. from Harvard University John F. Kennedy School of Government. The board of directors believes that Mr. Kessler experience in the taxadvantaged consumerbenefits industry, his background as a chief executive officer, and his training as a tax specialist qualify him to serve on our board of directors.Jon Kessler Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jon Kessler against HealthEquity stock is an integral part of due diligence when investing in HealthEquity. Jon Kessler insider activity provides valuable insight into whether HealthEquity is net buyers or sellers over its current business cycle. Note, HealthEquity insiders must abide by specific rules, including filing SEC forms every time they buy or sell HealthEquity'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jon Kessler over two months ago Disposition of 1511 shares by Jon Kessler of HealthEquity at 78.9334 subject to Rule 16b-3 | ||
Jon Kessler over three months ago Disposition of 2781 shares by Jon Kessler of HealthEquity at 83.0782 subject to Rule 16b-3 | ||
Jon Kessler over three months ago Disposition of 2199 shares by Jon Kessler of HealthEquity at 83.6511 subject to Rule 16b-3 | ||
Jon Kessler over six months ago Disposition of 6279 shares by Jon Kessler of HealthEquity at 74.2552 subject to Rule 16b-3 |
HealthEquity Management Efficiency
The company has Return on Asset of 0.034 % which means that on every $100 spent on assets, it made $0.034 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0515 %, implying that it generated $0.0515 on every 100 dollars invested. HealthEquity's management efficiency ratios could be used to measure how well HealthEquity manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.13 in 2024, whereas Return On Capital Employed is likely to drop 0.04 in 2024. At this time, HealthEquity's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 51 M in 2024, whereas Other Assets are likely to drop 0.95 in 2024.Similar Executives
| Found 2 records | CEO Age | ||
| Shane Trigg | Appfolio | 48 | |
| Brian Mueller | Grand Canyon Education | 70 | |
Management Performance
| Return On Equity | 0.0515 | ||||
| Return On Asset | 0.034 |
HealthEquity Leadership Team
Elected by the shareholders, the HealthEquity's board of directors comprises two types of representatives: HealthEquity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HealthEquity. The board's role is to monitor HealthEquity's management team and ensure that shareholders' interests are well served. HealthEquity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HealthEquity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cheryl King, Executive Officer | ||
| Elimelech Rosner, Executive CTO | ||
| Tia Padia, Executive Officer | ||
| Richard Putnam, IR Contact Officer | ||
| Larry Trittschuh, Executive Vice President Chief Security Officer | ||
| James Lucania, CFO VP | ||
| Delano JD, General VP | ||
| Jon Kessler, CEO and President and Director | ||
| Angelique Hill, Executive Vice President - Operations | ||
| Darcy Mott, CFO, Executive VP and Treasurer | ||
| Stephen Neeleman, Vice Chairman of the Board, Founder | ||
| Delano Ladd, Executive Vice President General Counsel and Corporate Secretary | ||
| Brad Bennion, Senior Development | ||
| Tyson Murdock, Ex CFO | ||
| Steve Lindsay, Executive Management | ||
| Kamesh Tumsi, Senior Product |
HealthEquity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HealthEquity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0515 | ||||
| Return On Asset | 0.034 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 9.78 B | ||||
| Shares Outstanding | 87.32 M | ||||
| Shares Owned By Insiders | 2.06 % | ||||
| Shares Owned By Institutions | 97.94 % | ||||
| Number Of Shares Shorted | 4.27 M | ||||
| Price To Earning | 525.29 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.